Transplacental Transfer and Fetal Pharmacodynamics of Sildenafil in the Pregnant Sheep Model
- 16 June 2021
- journal article
- research article
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 48 (6) , 411-420
Abstract
Background: Sildenafil is a phosphodiesterase-5 inhibitor considered for antenatal use for a variety of indications. We sought to assess sildenafil pharmacokinetics in the pregnant ewe and fetus and evaluate its physiological fetal effects. Methods: Twelve fetal lambs (127–133 days GA, term 145) were chronically catheterized in utero. Ewes received different doses of sildenafil, either via subcutaneous injection (1.6, 2.0 mg/kg/day) or intravenous (IV) infusion (3, 5, 7, 10, and 12 mg/kg/day). Maternal and fetal sildenafil concentrations and metabolic status (blood gas analysis) were measured at given intervals. The fetal heart rate, pulmonary blood flow, systemic and aortic pressure, and maternal uterine artery pressure were continuously monitored. Results: The transplacental sildenafil transfer was 2.9% (range: 1.4–7.8%), preventing attainment of fetal target concentrations without toxic maternal levels. IV sildenafil infusion induced an immediate, temporary, dose-dependent reduction of pulmonary vascular resistance (38–78%) and increased both pulmonary blood flow (32–132%) and heart rate (13–49%), with limited nonlinear dose-dependent effects on systemic and pulmonary pressures. Fetal and maternal blood gases and maternal uterine artery pressures were unaffected by sildenafil infusion. Conclusion: In sheep, transplacental transfer of sildenafil is extremely low. Though, minimal fetal sildenafil concentrations induce an acute transient pulmonary vasodilation, well-tolerated by the fetus and ewe.Keywords
This publication has 35 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial HypertensionCirculation, 2012
- Antenatal Sildenafil Treatment Attenuates Pulmonary Hypertension in Experimental Congenital Diaphragmatic HerniaCirculation, 2011
- Sildenafil citrate therapy for severe early-onset intrauterine growth restrictionBJOG: An International Journal of Obstetrics & Gynaecology, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Sildenafil Citrate Treatment Enhances Amino Acid Availability in the Conceptus and Fetal Growth in an Ovine Model of Intrauterine Growth RestrictionThe Journal of Nutrition, 2010
- A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of PreeclampsiaHypertension in Pregnancy, 2009
- The pregnant sheep as a model for human pregnancyTheriogenology, 2008
- Effects of Phosphodiesterase 5 Inhibitor on Pulmonary Vascular Reactivity in the Fetal LambThe Annals of Thoracic Surgery, 2006
- The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-StateClinical Pharmacokinetics, 1988
- Plasma Protein Binding of Drugs in PregnancyClinical Pharmacokinetics, 1982